I-3-Indoleacetonitrile CAS 771-51-7 Ubunyulu > 99.0% (HPLC) Factory High Quality

Inkcazelo emfutshane:

Igama leKhemikhali: 3-Indoleacetonitrile

CAS: 771-51-7

Ubunyulu: >99.0% (HPLC)

Imbonakalo: Mthubi oKhanyayo ukuya kwiPowder eBrown eKhanyayo

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-3-Indoleacetonitrile (i-CAS: 771-51-7) enomgangatho ophezulu, imveliso yorhwebo.Wamkelekile kwiodolo.

Iipropati zeMichiza:

Igama leMchiza	3-Indoleacetonitrile
Izithethantonye	Indole-3-Acetonitrile;I-2-(1H-Indol-3-yl) i-acetonitrile
Inombolo yeCAS	771-51-7
Inombolo yeCAT	RF-PI1602
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C10H8N2
Ubunzima beMolekyuli	156.19
Indawo yokunyibilika	33.0~36.0℃ (izibane)
Ukuxinana	1.1566
Ukunyibilika	NONE
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umthubi oKhanyayo ukuya kwiPowder emdaka
Ubunyulu / Indlela yokuHlalutya	>99.0% (HPLC)
Ilahleko ekomisweni	<1.00%
Ukungacoceki Okukodwa	<0.50%
Ukungcola ngokupheleleyo	<1.00%
I-1 H NMR Spectrum	Ukungqinelana Nolwakhiwo
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	AbaPhakathi bamayeza

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-3-Indoleacetonitrile (CAS: 771-51-7),I-Reactant ukulungiselela: I-Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles njenge-anticancer immunomodulators enokubakho;i-histone deacetylase inhibitors;I-kinase inhibitors enokwenzeka;I-Kv7/KCNQ i-activators ye-potassium channel;I-Kinesin-Specific MKLP-2 Inhibitor;Amayeza okubulala izitshabalalisi;Ii-agent ezinokubakho zomhlaza we-PET;I-Agonists ye-Farnesoid X Receptor (FXR) njengonyango lwe-atherosclerosis;i-butyrylcholinesterase inhibitors;I-Necroptosis inhibitors.